CD27 Molecule (CD27) Peptide
Quick Overview for CD27 Molecule (CD27) Peptide (ABIN940410)
Target
Origin
Source
Application
-
-
Peptide Type
- Synthetic
-
Sequence
- LHQRRKYRSN KGESPVEPAE PCRYSCPREE EGSTIPIQED YRKPEPACSP
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of CD27 antibody,
Alternative Names: CD27 control peptide, CD27 antibody Blocking Peptide, Anti-CD27 Blocking Peptide, CD27 molecule Blocking Peptide, MGC20393 Blocking Peptide, S152 Blocking Peptide, T14 Blocking Peptide, TNFRSF7 Blocking Peptide, Tp55 Blocking Peptide, CD27, CD-27, CD 27, CD-27 Blocking Peptide, CD 27 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- CD27 (CD27 Molecule (CD27))
-
Background
- The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptor is required for generation and long-term maintenance of T cell immunity. It binds to ligand CD70, and plays a key role in regulating B-cell activation and immunoglobulin synthesis. This receptor transduces signals that lead to the activation of NF-kappaB and MAPK8/JNK. Adaptor proteins TRAF2 and TRAF5 have been shown to mediate the signaling process of this receptor. CD27-binding protein (SIVA), a proapoptotic protein, can bind to this receptor and is thought to play an important role in the apoptosis induced by this receptor.
-
Molecular Weight
- 27 kDa
Target
-